Family planning and contraception in people with multiple sclerosis: perspectives for obstetricians, gynaecologists, and other health care professionals involved in reproductive planning

Gabriele S. Merki‐Feld(University Hospital of Zurich), Rossella E. Nappi(Foundation Center), Maria K. Houtchens(Brigham and Women's Hospital), Zeliha Tülek(Nightingale Hospital), Kerstin Hellwig(St. Josef-Hospital), Riley Bove, Jan Hillert, Kurt Marhardt(Merck KGaA, Darmstadt (Germany)), Egon Stenager(Copenhagen University Hospital), Manuela Simoni(University of Modena and Reggio Emilia), Lisa B. Haddad(Population Council), Scott Montgomery(St. Michael's Hospital), Heidi Thompson(Southern Health and Social Care Trust), Melinda Magyari(University of Copenhagen)
The European Journal of Contraception & Reproductive Health Care
December 16, 2024
10.1080/13625187.2024.2434843
Cited by 5

Related Papers

Multiple Sclerosis Severity Score
|Neurology|2005|957
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|587
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
|The Lancet Neurology|2025|314
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303